TWI680772B - A use of lactobacillus plantarum gmnl-6 composition for caring skin - Google Patents
A use of lactobacillus plantarum gmnl-6 composition for caring skin Download PDFInfo
- Publication number
- TWI680772B TWI680772B TW107104932A TW107104932A TWI680772B TW I680772 B TWI680772 B TW I680772B TW 107104932 A TW107104932 A TW 107104932A TW 107104932 A TW107104932 A TW 107104932A TW I680772 B TWI680772 B TW I680772B
- Authority
- TW
- Taiwan
- Prior art keywords
- skin
- composition
- external
- item
- patent application
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 16
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 15
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 15
- 108010035532 Collagen Proteins 0.000 claims abstract description 16
- 102000008186 Collagen Human genes 0.000 claims abstract description 16
- 229920001436 collagen Polymers 0.000 claims abstract description 15
- 230000036559 skin health Effects 0.000 claims abstract description 13
- 230000014509 gene expression Effects 0.000 claims abstract description 8
- 230000028327 secretion Effects 0.000 claims abstract description 8
- 239000002537 cosmetic Substances 0.000 claims abstract description 7
- 239000011148 porous material Substances 0.000 claims description 12
- 239000006210 lotion Substances 0.000 claims description 10
- 230000006870 function Effects 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 6
- 230000001815 facial effect Effects 0.000 claims description 4
- 230000003020 moisturizing effect Effects 0.000 claims description 4
- 239000007934 lip balm Substances 0.000 claims description 2
- 239000002884 skin cream Substances 0.000 claims description 2
- 239000006041 probiotic Substances 0.000 abstract description 29
- 235000018291 probiotics Nutrition 0.000 abstract description 29
- 230000000529 probiotic effect Effects 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 63
- 210000004027 cell Anatomy 0.000 description 13
- 239000000839 emulsion Substances 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 241000186660 Lactobacillus Species 0.000 description 8
- 229940039696 lactobacillus Drugs 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- 208000002874 Acne Vulgaris Diseases 0.000 description 6
- 206010000496 acne Diseases 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 102100031872 Serine palmitoyltransferase small subunit A Human genes 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 101000704221 Homo sapiens Serine palmitoyltransferase small subunit A Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 210000001626 skin fibroblast Anatomy 0.000 description 3
- 230000036548 skin texture Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical compound CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010050808 Procollagen Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 101150097623 1B gene Proteins 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 1
- FBNAWLJSQORPAX-UHFFFAOYSA-N 4-methyl-3-propan-2-ylphenol Chemical compound CC(C)C1=CC(O)=CC=C1C FBNAWLJSQORPAX-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 241000756137 Hemerocallis Species 0.000 description 1
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 241000208473 Macadamia ternifolia Species 0.000 description 1
- 241000123107 Phellinus Species 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 101710094012 Serine palmitoyltransferase small subunit A Proteins 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000019730 animal feed additive Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- -1 decomposers Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007108 local immune response Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229920001427 mPEG Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229940048869 o-cymen-5-ol Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000020245 plant milk Nutrition 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 229940093932 potassium hydroxide Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037070 skin defense Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本發明提供一種益生菌用於製備皮膚保健組合物的用途,其中該益生菌包含植物乳桿菌(Lactobacillus plantarum GMNL-6),其寄存編號為BCRC 910777或CCTCC M 2017765。所述組合物可為外用擦藥、外用醫藥品、外用保養品或化妝品,並可藉由促進膠原蛋白分泌或神經醯胺合成酶之表達,以達到改善皮膚狀況或美學外觀之功效。 The present invention provides the use of a probiotic for preparing a skin health care composition, wherein the probiotic contains Lactobacillus plantarum GMNL-6, and its deposit number is BCRC 910777 or CCTCC M 2017765. The composition can be an external rub, an external medicine, an external care product, or a cosmetic, and can improve the skin condition or aesthetic appearance by promoting collagen secretion or expression of neuroamide synthase.
Description
本發明係關於乳桿菌分離株,用於皮膚保健之技術領域。 The invention relates to a lactobacillus isolate used in the technical field of skin care.
目前市面上強調皮膚用之益生菌產品相當有限,在回顧性文獻指出益生菌影響皮膚表徵的途徑有二,一為直接將益生菌作用於患部,可影響局部免疫反應或直接抑制皮膚壞菌生長;二為經由口服益生菌至腸道後,影響腸道菌相及免疫反應,進而影響遠端皮膚之變化(Jeong JH et al,2016),舉例來說,口服益生菌於改善或預防異位性皮膚炎(Atopic Dermatitis AD)應用已非常廣泛。在回顧性研究(Baquerizo Nole KL et al,2014,Fuchs-Tarlovsky V et al,2016,Jeong JH et al,2016)亦發現,某些乳酸菌利用其產生之醋酸、乳酸、丁二酮、鞘磷脂經磷脂酶、玻尿酸或其表面物質...等,達到促進皮膚健康之效果。整體來說,皮膚用益生菌主要有幾方面的功效:例如:改善痤瘡(Kim J,Ko Y et al,2010)、抗紫外線UV光傷害之能力(Ra J et al,2014)、促進傷口癒合之效果(Peral MC et al,2009)、抗黑色素形成之效果(Chan CF et al,2014)。 At present, the market emphasizes that probiotic products for skin use are quite limited. In the retrospective literature, there are two ways for probiotics to affect skin characterization. One is to directly apply probiotics to the affected part, which can affect the local immune response or directly inhibit the growth of skin bad bacteria. ; Second, after oral administration of probiotics to the intestine, it affects the intestinal bacterial phase and immune response, which in turn affects the changes of the remote skin ( Jeong JH et al , 2016 ) , for example, oral probiotics can improve or prevent ectopic Dermatitis (Atopic Dermatitis AD) has been widely used. A retrospective study (Baquerizo Nole KL et al , 2014, Fuchs-Tarlovsky V et al , 2016, Jeong JH et al , 2016) also found that certain lactic acid bacteria use the acetic acid, lactic acid, butanedione, and sphingomyelin produced by Phospholipase, hyaluronic acid or its surface substances... etc., to achieve the effect of promoting skin health. Overall, probiotics for skin mainly have several effects: for example: improving acne (Kim J, Ko Y et a l, 2010), the ability to resist ultraviolet UV light damage (Ra J et al, 2014), promoting wounds Healing effect (Peral MC et al , 2009), anti-melanin formation effect (Chan CF et al , 2014).
過去利用益生菌改善皮膚健康之臨床人體試驗文獻不多,且大多以口服為主,益生菌添加於皮膚外用劑型之研究相當少,其中一篇以 比菲德氏龍根菌菌體萃取物調製而成的乳液,擦拭29天後對於敏感性肌膚的保濕方面具有明顯之效果(N=66人,女性)(Gueniche A et al,2010),而乳酸桿菌之應用相關臨床報導則仍缺乏。 In the past, there have been few clinical human trials on the use of probiotics to improve skin health, and most of them are mainly oral. The research on the use of probiotics in external skin dosage forms is quite small. One of them is prepared by the extract of Phellinus rhizogenes. The resulting emulsion has a significant effect on moisturizing sensitive skin after 29 days of wiping (N=66 persons, female) (Gueniche A et al, 2010), and clinical reports on the application of Lactobacillus are still lacking.
皮膚中膠原蛋白主要功用是提供肌膚完整的水分補充、增加皮膚的彈性與表面的光澤。神經醯胺則是一種天然存在於體內皮膚角質層的細胞間隙間的脂質,是皮膚角質層脂質中最重要且比例最高的成分。主要功能為緊密接連維持角質層的脂質完整性,能防止水分的蒸發,並能抵禦外來病菌與傷害。本發明主要利用體外模式篩選具刺激人類皮膚纖維母細胞分泌及產生膠原蛋白及合成神經醯胺之益生菌,並進一步利用皮膚檢測儀器以證實益生菌乳液對皮膚之健康促進效果。 The main function of collagen in skin is to provide complete moisture replenishment of skin, increase skin elasticity and surface gloss. Neuroamide is a lipid that naturally exists in the intercellular spaces of the stratum corneum of the body, and is the most important and highest proportion of the stratum corneum lipid. The main function is to maintain the lipid integrity of the stratum corneum in close succession, prevent the evaporation of water, and resist foreign germs and injuries. The invention mainly uses an in vitro model to screen probiotics that stimulate human skin fibroblasts to secrete and produce collagen and synthesize neuroamides, and further uses skin detection instruments to confirm the health promotion effect of probiotic emulsions on the skin.
由於前揭益生菌在於皮膚保健領域之間研究並不廣泛,而亟待加以尋找有效改善之益生菌。由於膠原蛋白與神經醯胺已廣泛使用皮膚狀態探討及作用機制上,故本實驗乃利用膠原蛋白與神經醯胺探討益生菌對皮膚保健改善的影響,已找出可能具有改善皮膚狀態之植物乳桿菌Lactobacillus plantarum GMNL-6);進一步以VISIA高階數位膚質檢測儀檢測受測者皮膚參數。 Because the research on probiotics in the skin care field is not extensive, it is urgent to find probiotics that can be effectively improved. Since collagen and neuroamide have been widely used to discuss the skin condition and its mechanism of action, this experiment used collagen and neuroamide to explore the effects of probiotics on skin health improvement, and plant milk that may have improved skin condition has been identified Lactobacillus plantarum GMNL-6); further test the skin parameters of the subject with VISIA high-order digital skin quality tester.
本發明之目的在於提供一種益生菌用於皮膚保健之組合物的用途,其中該益生菌包含植物乳桿菌(Lactobacillus plantarum GMNL-6),其寄存編號為BCRC 910777或CCTCC M2017765。 The purpose of the present invention is to provide a use of a probiotic composition for skin health care, wherein the probiotic comprises Lactobacillus plantarum GMNL-6, and its deposit number is BCRC 910777 or CCTCC M2017765.
為達成前述發明目的,其中該植物乳桿菌GMNL-6係死菌體。 To achieve the aforementioned object of the invention, the Lactobacillus plantarum GMNL-6 is a dead cell.
為達成前述發明目的,其中該死菌體是將含菌液體經高溫高壓處理而得到。 In order to achieve the aforementioned object of the invention, the dead cells are obtained by treating the bacteria-containing liquid under high temperature and high pressure.
為達成前述發明目的,其中該組合物為外用擦藥、外用醫藥品、外用保養品或化妝品。 To achieve the aforementioned object of the invention, the composition is an external rub, an external pharmaceutical, an external care product, or a cosmetic.
為達成前述發明目的,其中該組合物可進一步包含藥學或化妝品學上可接受之載劑。 To achieve the aforementioned object of the invention, the composition may further comprise a pharmaceutically or cosmetically acceptable carrier.
為達成前述發明目的,其中該外用保養品是化妝水、乳液、護膚霜、保濕液、護唇膏、美容液面膜或洗面乳。 In order to achieve the aforementioned object of the invention, the external care product is a lotion, lotion, skin cream, moisturizing liquid, lip balm, cosmetic liquid mask or facial cleanser.
為達成前述發明目的,其中該皮膚保健是指改善皮膚狀況或美學外觀。 To achieve the aforementioned object of the invention, the skin care refers to improving the skin condition or aesthetic appearance.
為達成前述發明目的,其中該改善皮膚狀況是經由促進膠原蛋白分泌或神經醯胺合成酶之表達。 To achieve the aforementioned object of the invention, the improvement of the skin condition is through the promotion of collagen secretion or the expression of neuroamide synthase.
為達成前述發明目的,其中該皮膚保健係為降低皮膚斑點、毛孔、皺紋、紫外線斑或紫質之數量。 In order to achieve the aforementioned object of the invention, the skin health care system is to reduce the number of skin spots, pores, wrinkles, ultraviolet spots, or viologen.
為達成前述發明目的,其中該改善人類皮膚狀況或美學外觀,包含:(1)治療、減少、及/或預防細紋或皺紋;(2)縮小皮膚毛孔大小;(3)改善皮膚厚度、飽滿度、及/或緊致度;(4)改善皮膚柔軟性及/或柔軟度;(5)改善膚色、光澤及/或清透性;(6)增加原膠原蛋白及/或膠原蛋白產生;(7)改善彈性蛋白之維持及重塑;(8)改善皮膚紋理及/或促進重整;(9)改善皮膚障壁修復及/或功能;(10)改善皮膚輪廓外觀;(11)恢復皮膚光澤及/或亮度;(12)補充皮膚中之必需營養物及/或組分;(13)改善因更年期而變差之皮膚外觀;(14)改善皮膚保濕性;(15)增加皮膚彈性及/或彈力;(16)治療、減少、 及/或預防皮膚鬆弛;(17)減少色素斑點;(18)治療、減少、及/或預防粉刺或痤瘡;或其任何組合。 To achieve the aforementioned object of the invention, wherein the improvement of human skin condition or aesthetic appearance includes: (1) treatment, reduction, and/or prevention of fine lines or wrinkles; (2) reduction of skin pore size; (3) improvement of skin thickness and fullness Degree, and/or firmness; (4) improve skin softness and/or softness; (5) improve skin tone, gloss and/or clarity; (6) increase procollagen and/or collagen production; (7) Improve elastin maintenance and remodeling; (8) Improve skin texture and/or promote remodeling; (9) Improve skin barrier repair and/or function; (10) Improve skin contour appearance; (11) Restore skin Luster and/or brightness; (12) Supplement essential nutrients and/or components in the skin; (13) Improve skin appearance that deteriorates due to menopause; (14) Improve skin moisture retention; (15) Increase skin elasticity and /Or elasticity; (16) treatment, reduction, And/or prevent sagging skin; (17) reduce pigment spots; (18) treat, reduce, and/or prevent acne or acne; or any combination thereof.
為達成前述發明目的,其中該組合物中每公克包含1×107~1×1011個GMNL-6死菌體。 To achieve the aforementioned object of the invention, each gram of the composition contains 1×10 7 to 1×10 11 GMNL-6 dead cells.
為達成前述發明目的,其中該組合物中每公克較佳之死菌體個數為1×108~1×1010個。 To achieve the aforementioned object of the invention, the preferred number of dead cells per gram in the composition is 1×10 8 to 1×10 10 .
圖1A 膠原蛋白之蛋白表現 Figure 1A Collagen protein expression
圖1B 神經醯胺合成酶之基因表現 Figure 1B Gene expression of neuroamide synthase
圖2 以VISIA高階數位膚質檢測儀分析受測者斑點數量 Figure 2 Analysis of the number of spots on the subject by VISIA high-order digital skin quality detector
圖3 以VISIA高階數位膚質檢測儀分析受測者毛孔數量 Figure 3 Analysis of the subject's pore volume with VISIA high-order digital skin quality detector
圖4 以VISIA高階數位膚質檢測儀分析受測者皺紋數量 Figure 4 Analysis of the number of wrinkles on the subject with VISIA high-level digital skin quality detector
圖5 以VISIA高階數位膚質檢測儀分析受測者紫外線斑數量 Figure 5 Analysis of the number of UV spots on the subject by VISIA high-level digital skin quality detector
圖6 以VISIA高階數位膚質檢測儀分析受測者紫質數量 Figure 6 Analysis of the amount of purple pigment in the subjects with VISIA high-level digital skin texture detector
本說明書中所述之所有技術性及科學術語,除非另外有所定義,皆為該所屬領域具有通常技藝者可共同瞭解的意義。 All technical and scientific terms described in this specification, unless otherwise defined, are in the field and have the meaning commonly understood by those skilled in the art.
本發明之目的即在於提供一種益生菌用於皮膚保健之組合物的用途,其中該益生菌包含植物乳桿菌(Lactobacillus plantarum GMNL-6),其寄存編號為BCRC 910777或CCTCC M2017765。另,本發明亦關於藉由該組合物或該乳桿菌用以皮膚保健之新穎用途,其作用機制為 促進膠原蛋白分泌及神經醯胺之表達,以達成皮膚保健之功效。 The purpose of the present invention is to provide a use of a probiotic composition for skin care, wherein the probiotic comprises Lactobacillus plantarum GMNL-6, and its deposit number is BCRC 910777 or CCTCC M2017765. In addition, the present invention also relates to a novel use of the composition or the Lactobacillus for skin care. Its mechanism of action is to promote collagen secretion and neuroamide expression to achieve the effect of skin care.
其中該乳桿菌分離株亦包含其繼代培養之後代,或突變株,但仍具有與本發明所述之菌種特性、基因體(genomic)、或用途(用於抑制腸病毒)相同者。 The Lactobacillus isolates also include the progeny of their subculture, or mutant strains, but they still have the same characteristics, genomics, or uses (for the suppression of enteroviruses) as described in the present invention.
本文所述組合物係可包含,但不限於:食品、飲品、健康食品、動物飲水添加物、動物飼料添加物、動物用及人類用醫療組合物、食品添加物、飲料添加物等適用本發明之應用形式。 The compositions described herein may include, but are not limited to: foods, beverages, health foods, animal water additives, animal feed additives, animal and human medical compositions, food additives, beverage additives, etc. Application form.
術語"藥學或化妝品上可接受之載劑"意謂物質或組合物必須與調配物之其他成份相容,且對患者無害。 The term "pharmaceutically or cosmetically acceptable carrier" means that the substance or composition must be compatible with the other ingredients of the formulation and not harmful to the patient.
術語"萃取物(Cell Lysate)"可為自特定萃取步驟或系列萃取步驟獲得的單一萃取物,或者萃取物亦可為自若干獨立萃取步驟獲得的若干萃取物之組合。此等經組合萃取物因此亦涵蓋於術語「萃取物」內。 The term "Cell Lysate" may be a single extract obtained from a specific extraction step or series of extraction steps, or the extract may also be a combination of several extracts obtained from several independent extraction steps. These combined extracts are therefore also covered by the term "extract".
其中該藥學或化妝品上可接受之載劑可包含一或多種選自於下列的試劑:溶劑(solvent)、乳化劑(emulsifier)、懸浮劑(suspending agent)、分解劑(decomposer)、黏結劑(binding agent)、賦形劑(excipient)、安定劑(stabilizing agent)、螯合劑(chelating agent)、稀釋劑(diluent)、膠凝劑(gelling agent)、防腐劑(preservative)、潤滑劑(lubricant)、表面活性劑(surfactant),及其他類似或適用本發明之載劑。 The pharmaceutically or cosmetically acceptable carrier may include one or more agents selected from the group consisting of solvents, emulsifiers, suspending agents, decomposers, and binders ( binding agent, excipient, stabilizing agent, chelating agent, diluent, gelling agent, preservative, lubricant , Surfactant (surfactant), and other similar or applicable carriers of the present invention.
上述組合物中,亦可視需要適宜地添加一或多種以上製劑領域內通常使用之溶解補助劑、緩衝劑、保存劑、着色劑、香料、風味劑等。 One or more kinds of dissolution aids, buffers, preservatives, colorants, flavors, flavors, etc. commonly used in the field of formulations can also be appropriately added to the above composition as needed.
此外,本發明所發現之新穎菌種,亦可與其他習知菌種一併被包含於一組成物中。 In addition, the novel strains discovered in the present invention can also be included in a composition together with other conventional strains.
本發明所提供之組合物及其用於皮膚保健之用途,其使用劑型,可視需求適宜調整,並未特別限定,較佳者為皮膚外用劑型。 The composition provided by the present invention and its use for skin health care, its dosage form can be adjusted according to needs, and is not particularly limited, and the external skin dosage form is preferred.
本發明係以下面的實施例予以示範闡明,但本發明不受下述實施例所限制。本發明所用之藥物、生物材料皆市售易於取得,下列僅為示例可取得之管道。 The present invention is exemplified and illustrated by the following examples, but the present invention is not limited by the following examples. The drugs and biological materials used in the present invention are all commercially available, and the following are only examples of available channels.
本發明係以下面的實施例予以示範闡明,但本發明不受下述實施例所限制。 The present invention is exemplified and illustrated by the following examples, but the present invention is not limited by the following examples.
從菌種庫中挑選具皮膚保健功效的植物乳桿菌,該乳桿菌之寄存編號、寄存日期及菌株名稱,如表一所示。 Select the Lactobacillus plantarum with skin health care effect from the bacterial species library. The deposit number, deposit date and strain name of the lactobacillus are shown in Table 1.
實施例1 GMNL-6可促進膠原蛋白分泌及神經醯胺合成酶之表達Example 1 GMNL-6 can promote collagen secretion and the expression of neuroamide synthase
1-1死菌製備步驟:1-1 Dead bacteria preparation steps:
自凍管接種植物乳桿菌(Lactobacillus plantarum;GMNL-6)1ml MRS broth,並於37℃有氧下靜置培養20小時。次日,取15μl隔夜培養菌液至1.5ml MRS broth(1%二次活化),37℃有氧下靜置培養20小時,以PBS清洗一次,以OD600nm推估菌數,並將菌數調整為1×1010 cells/ml,並進行高溫高壓滅菌121℃,15分鐘後備用。 Lactobacillus plantarum (GMNL-6) 1 ml MRS broth was inoculated from the freezing tube and incubated at 37°C for 20 hours under aerobic conditions. The next day, take 15μl of overnight culture solution to 1.5ml MRS broth (1% secondary activation), incubate at 37°C for 20 hours under aerobic culture, wash once with PBS, estimate the number of bacteria with OD600nm, and adjust the number of bacteria It is 1×10 10 cells/ml, and is autoclaved at 121°C, and is ready for use after 15 minutes.
1-2人類皮膚纖維母細胞(human skin fibroblast;Hs68)細胞模式:1-2 Human skin fibroblast (Hs68) cell model:
分析細胞培養液之膠原蛋白(collagen)步驟:將Hs68 cells種至6well plate(2×105cells/well),隔夜後以PBS清洗兩次,並換成serum free之培養基(medium),並加入1×109cells/ml之GMNL-6死菌菌液,處理24小時後,收集上清液。 Steps to analyze collagen in cell culture fluid: Seed Hs68 cells to 6well plate (2×10 5 cells/well), wash twice with PBS overnight, and change to serum free medium (medium), and add 1×10 9 cells/ml GMNL-6 dead bacteria solution, after 24 hours of treatment, collect the supernatant.
將上清液稀釋10倍後,利用Procollagen type I C-peptide EIA kit(TaKaRa,#MK101)進行分析。 After diluting the supernatant 10-fold, analysis was performed using Procollagen type I C-peptide EIA kit (TaKaRa, #MK101).
分析細胞內神經醯胺合成酶基因(Serine palmitoyltransferase small subunit A,SPTSSA)步驟: Steps for analyzing intracellular neuroamide synthase gene (Serine palmitoyltransferase small subunit A, SPTSSA):
Hs68 cells種至6well plate(2×105/well),隔夜後以PBS清洗兩次,並換成serum free之培養基(medium),並加入1×109cells/ml之死菌菌液,處理24小時後,收集細胞萃取物,抽取RNA後轉成cDNA,並進行神經醯胺合成酶基因(SPTSSA)及持家基因(β-actin)的定量PCR分析。 Hs68 cells are seeded to 6well plate (2×10 5 /well), washed twice with PBS overnight, and replaced with serum free medium (medium), and added 1×10 9 cells/ml of dead bacteria liquid for treatment After 24 hours, the cell extracts were collected, RNA was extracted and converted into cDNA, and quantitative PCR analysis of the neuroamide synthase gene (SPTSSA) and housekeeping gene (β-actin) was performed.
實驗結果:Experimental results:
先前利用人類皮膚纖維細胞體外模式篩選平台,從數十隻乳酸桿菌菌株中篩選出一隻具皮膚保健功效之植物乳桿菌(L.plantarum)GMNL-6,其促進膠原蛋白分泌的能力。更進一步於相同模式中,實驗結果(圖1)均發現GMNL-6同時具有促進膠原蛋白分泌的能力及刺激細胞內神經醯胺合成酶(SPTSSA)產生的能力,神經醯胺合成酶為體內神經醯胺合成過程中必須之必須分子,其上升亦代表體內神經醯胺製造增加,神經醯胺在 肌膚美容上具有強化肌膚保濕、增加肌膚防禦、抑制酪胺酸酶(Tyrosinase)的生成。 Previously with human skin fibroblasts in vitro screening platform model, from dozens of Lactobacillus strains were screened Lactobacillus (L. plantarum) having a skin care effect of GMNL-6, its capacity to promote secretion of collagen. Further in the same mode, the experimental results (Figure 1) found that GMNL-6 has both the ability to promote collagen secretion and the ability to stimulate the production of intracellular neurosynthetase (SPTSSA), which is a nerve in the body. The necessary molecule in the synthesis process of amides, its rise also represents an increase in the production of neuroamides in the body. Neuroamides in skin beauty have the functions of strengthening skin moisturizing, increasing skin defense, and inhibiting the production of tyrosinase.
實施例2:植物乳桿菌GMNL-6益生菌乳液具有改善全臉膚質的功用Example 2: Lactobacillus plantarum GMNL-6 probiotic emulsion has the function of improving the skin quality of the entire face
2-1實驗步驟:2-1 Experimental steps:
1.試驗人數:五名女性(30~40歲)。 1. Number of participants: five women (30-40 years old).
2.評估地點:嘉南藥理大學機能性化粧品開發與評估研究中心。 2. Evaluation location: Functional Cosmetics Development and Evaluation Research Center of Jianan Pharmaceutical University.
3.試驗前,先使用洗面乳將臉部清洗乾淨,進行以VISIA高階數位膚質檢測儀全臉膚質診斷,並紀錄數值(day0) 3. Before the test, first clean the face with facial cleanser, perform a full-face skin diagnosis using VISIA high-level digital skin detector, and record the value (day0)
4.試驗期間每日早、晚洗臉後塗抹測試樣品(除乳液外,左右臉其他保養條件一致): 4. Apply test samples after washing your face in the morning and evening every day during the test (except for lotion, other maintenance conditions of the left and right faces are the same):
-左半臉使用:對照組乳液(基質) -Use on the left half of the face: control lotion (matrix)
-右半臉使用:益生菌乳液(基質+GMNL-6死菌) -Use on the right half of the face: probiotic emulsion (matrix + GMNL-6 dead bacteria)
5.使用四週後進行全臉膚質診斷(day 28),先使用洗面乳將臉部清洗乾淨,再進行全臉膚質診斷,並紀錄數值。 5. After four weeks of use, perform a full-face skin diagnosis (day 28), first cleanse the face with facial cleanser, then perform a full-face skin diagnosis, and record the value.
2-2乳液成份與益生菌濃度:2-2 Emulsion ingredients and probiotic concentration:
1.乳液全成分(基質):Water、Polyglyceryl-3/Methyl glucose/Distearate、GlycerylTrioctanoin、Macadamia Ternifolia Seed Oil、Propanediol、PEG/PPG/Polybutylene Glycol-8/5/3 Glycerin、Cetyl Alcohol、MyristylMyristate、Glycerin、GlycosylTrehalose/Hydrogenated Starch Hydrolysate、Rice Ferment Filtrate(Sake)、Saccharomyces/Daylily Flower Ferment Filtrate、Bis-PEG/PPG-20/15 PEG/PPG-20/5Dimethicone/Methoxy PEG/PPG-25/4 DimethiconeCaprylic/Capric Triglyceride、Sodium Polyacrylate、Phenoxyethanol、o-Cymen-5-ol、Xanthan Gum、Potassium Hydroxide。 1. Full composition of emulsion (matrix): Water, Polyglyceryl-3/Methyl glucose/Distearate, GlycerylTrioctanoin, Macadamia Ternifolia Seed Oil, Propanediol, PEG/PPG/Polybutylene Glycol-8/5/3 Glycerin, Cetyl Alcohol, MyristylMyristate, Glycerin, GlycosylTrehalose/Hydrogenated Starch Hydrolysate, Rice Ferment Filtrate(Sake), Saccharomyces/Daylily Flower Ferment Filtrate, Bis-PEG/PPG-20/15 PEG/PPG-20/5Dimethicone/Methoxy PEG/PPG-25/4 DimethiconeCaprylic/Capric Triglyceride, Sodium Polyacrylate, Phenoxyethanol, o-Cymen-5-ol, Xanthan Gum, Potassium Hydroxide.
2.乳液中GMNL-6濃度:1×109cells/g乳液 2. GMNL-6 concentration in emulsion: 1×10 9 cells/g emulsion
2-3評估方式:2-3 Evaluation method:
1.利用VISIA高階數位膚質檢測儀進行膚質檢測,通過1200萬像素的相機和不同的三種光源(普通光、UV光、偏光)對面部進行高清晰度拍照,然後利用軟體分析臉部固定範圍之膚質,可以準確的得到斑點、毛孔、皺紋、紋理、紫斑及紫質等皮膚參數,以評估皮膚基底層潛在的狀況。進而了解肌膚存在問題,以此評估使用乳液前後的數據變化。其測試結果根據性別,年齡而得到的一個合格正常範圍數據的對比,藉此可作為產品之有效性評估。 1. Use VISIA high-level digital skin quality detector for skin quality detection, take a high-resolution photo of the face with a 12-megapixel camera and three different light sources (general light, UV light, polarized light), and then use the software to analyze the face fixation The range of skin quality can accurately obtain skin parameters such as spots, pores, wrinkles, texture, purple spots and purple matter to evaluate the underlying condition of the skin basal layer. In order to understand the skin problems, we can evaluate the data changes before and after using the lotion. The test results are compared with a qualified normal range data based on gender and age, which can be used to evaluate the effectiveness of the product.
2.經由全臉膚質診斷儀所測得的膚質參數(包含:斑點、毛孔、皺紋、紫斑及紫質),來評估每個人自己的左臉(對照組乳液)與右臉(益生菌乳液)在使用前(day0)與使用後(day 28)的分值差異。分值變化(%)之計算公式如下所示:
實驗結果:Experimental results:
五位受試者(NO.1~5)分別使用對照組乳液(左臉)及益生菌 乳液(右臉),28天後,經由VISIA高階數位膚質檢測儀,分析五位受測者皮膚參數,包含:斑點(圖2)、毛孔(圖3)、皺紋(圖4)、紫斑(圖5)及紫質(圖6),經每個人與自己左臉比較,評估使用益生菌乳液組可得到較好的膚質改善數據,每評估項至少都有三人以上獲得改善,尤其是斑點及毛孔,更高達80~100%的人是有明顯改善的。因此整體而言,益生菌具改善皮膚膚質之效果,尤其是在淡化斑點及縮小毛孔功效最為顯著。 Five subjects (NO.1~5) used the control lotion (left face) and probiotics respectively Emulsion (right face), 28 days later, the skin parameters of five subjects were analyzed by VISIA high-level digital skin tester, including: spots (Figure 2), pores (Figure 3), wrinkles (Figure 4), purple spots ( Figure 5) and Violet (Figure 6). After comparing each person's left face with each other, the use of probiotic lotion group can be evaluated to obtain better skin quality improvement data. At least three or more people improved in each evaluation item, especially spots and Pores, up to 80~100%, have been significantly improved. Therefore, in general, probiotics have the effect of improving skin texture, especially in lightening spots and reducing pores.
皮膚中的膠原蛋白及神經醯胺隨著年齡增長或不良生活習慣之影響,會出現逐漸流失之情形,因此補充及回復皮膚中膠原蛋白及神經醯胺含量,對皮膚保健、防皺、抗UV傷害、抗衰老相當重要。本專利評估經由體外試驗發現,植物乳桿菌GMNL-6可同時促進膠原蛋白分泌及神經醯胺合成酶之表達,代表GMNL-6具有皮膚方面之特殊效果。由人體臨床實驗經VISIA高階數位膚質檢測儀觀察,植物乳桿菌GMNL-6益生菌乳液具有改善全臉膚質的功用,包含:斑點、毛孔、皺紋、紫斑及紫質,每項至少都有三人以上獲得改善,尤其是淡化斑點及縮小毛孔,更高達80~100%的人是有效的;此外紫質之降低,表示痤瘡桿菌之生長受到抑制,對於改善青春痘及粉刺應有所助益。益生菌於皮膚人體臨床的應用多是口服,而直接將乳酸桿菌死菌添加於乳液之臨床試驗研究是少的,且利用同時比較自己左右臉的評估方式,減少其他保養品干擾及其他個體差異之變因。且五名使用GMNL-6益生菌乳液者使用四週後,並無出現任何過敏及不適症狀。因此,利用植物乳桿菌(Lactobacillus plantarum;GMNL-6)應用於皮膚保養品是相當安全而且無副作用,應可作為未來促進皮膚健康及防止膚質老化之更佳選擇。 Collagen and neuroamide in the skin will gradually lose with the increase of age or the influence of unhealthy living habits. Therefore, supplement and restore the content of collagen and neuroamide in the skin, which is good for skin health, anti-wrinkle and anti-UV Damage and anti-aging are very important. The evaluation of this patent found through in vitro experiments that Lactobacillus plantarum GMNL-6 can simultaneously promote collagen secretion and the expression of neuroamide synthase, which represents that GMNL-6 has a special skin effect. Observed by human clinical experiments through VISIA high-level digital skin quality tester, Lactobacillus plantarum GMNL-6 probiotic emulsion has the function of improving the skin quality of the entire face, including: spots, pores, wrinkles, purple spots and purple texture, at least three people in each item The above is improved, especially to lighten the spots and reduce the pores, up to 80-100% of people are effective; in addition, the reduction of porphyrin indicates that the growth of acne bacilli is inhibited, which should help improve acne and acne. The clinical application of probiotics in human skin is mostly oral, and clinical trials of directly adding dead bacteria of Lactobacillus to emulsion are few, and the evaluation method of comparing their left and right faces at the same time is used to reduce interference with other skin care products and other individual differences. Cause of change. And five people who used GMNL-6 probiotic emulsion did not show any symptoms of allergy and discomfort after using it for four weeks. Therefore, the use of Lactobacillus plantarum (GMNL-6) for skin care products is quite safe and has no side effects. It should be a better choice for promoting skin health and preventing skin aging in the future.
上述多項功效,實屬充分符合新穎性及進步性之法定發明專利要件,爰依法提出申請,懇請 貴局核准本件發明專利申請案,以勵發明。 The above-mentioned multiple functions are in full compliance with the statutory invention patent requirements for novelty and progress. You must file an application in accordance with the law and urge your office to approve this application for an invention patent to encourage invention.
國內寄存資訊【請依寄存機構、日期、號碼順序註記】 Domestic storage information [Please note in order of storage institution, date, number]
新竹食品工業發展研究所生物資源保存及研究中心、寄存日期為2017年4月14日、寄存編號為BCRC 910777。 Biological Resources Preservation and Research Center of Hsinchu Food Industry Development Institute, the deposit date is April 14, 2017, and the deposit number is BCRC 910777.
國外寄存資訊【請依寄存國家、機構、日期、號碼順序註記】 Overseas hosting information [Please note in order of hosting country, institution, date, number]
中國、寄存日期為2017年11月3日、寄存編號為CCTCC M 2017765 China, deposit date is November 3, 2017, deposit number is CCTCC M 2017765
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW107104932A TWI680772B (en) | 2018-02-12 | 2018-02-12 | A use of lactobacillus plantarum gmnl-6 composition for caring skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW107104932A TWI680772B (en) | 2018-02-12 | 2018-02-12 | A use of lactobacillus plantarum gmnl-6 composition for caring skin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201934114A TW201934114A (en) | 2019-09-01 |
| TWI680772B true TWI680772B (en) | 2020-01-01 |
Family
ID=68618347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW107104932A TWI680772B (en) | 2018-02-12 | 2018-02-12 | A use of lactobacillus plantarum gmnl-6 composition for caring skin |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI680772B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107105747A (en) * | 2014-09-23 | 2017-08-29 | 韩国韩医学研究院 | The dead thalline of lactic acid bacteria comprising discontinuous sterilization is used for the composition of skin moisture-keeping or improvement wrinkle as active ingredient |
-
2018
- 2018-02-12 TW TW107104932A patent/TWI680772B/en active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107105747A (en) * | 2014-09-23 | 2017-08-29 | 韩国韩医学研究院 | The dead thalline of lactic acid bacteria comprising discontinuous sterilization is used for the composition of skin moisture-keeping or improvement wrinkle as active ingredient |
Non-Patent Citations (2)
| Title |
|---|
| 【J.Microbiol.Biotechnol.】,2015,Vol.25,no.12,p.2160-2168 * |
| 【J.Microbiol.Biotechnol.】,2015,Vol.25,no.12,p.2160-2168。 |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201934114A (en) | 2019-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11103443B2 (en) | Compositions and methods for preventing, slowing, and reversing skin aging | |
| EP2082731B1 (en) | Use of a combination of hesperidin and a micro-organism to act on the barrier function of the skin | |
| EP2332520B1 (en) | Lactobacillus paracasei for treating age spots and / or melasma | |
| TWI693899B (en) | Fermentation product of punica granatum and uses thereof | |
| US20230338270A1 (en) | Cosmetic composition for skin improvement comprising, as active ingredients, polysaccharides, yeast extract, and strain fermentation product with characteristics of probiotics | |
| US20150044317A1 (en) | Topical Compositions for Reducing Visible Signs of Aging and Methods of Use Thereof | |
| CN109715183A (en) | The new beauty and make-up and/or nutrition and health care or dermatological use of yeast extract | |
| TWI774046B (en) | Use of solanum muricatum fermented liquid for preparing a composition for promoting skin anti-aging ability, promoting anti-glycation ability, reducing melanin content, increasing skin moisturization, reducing skin texture, reducing skin wrinkles, reducing skin redness and/or reducing fat | |
| TWI819234B (en) | Use of lactobacillus rhamnosus tci366 and/or its metabolites for improving skin conditions | |
| US11007137B2 (en) | Use of lactobacillus plantarum GMNL-6 composition for skin care | |
| KR102015180B1 (en) | Cosmetic composition comprising the fermented milk-cream broth of lactic acid bacteria | |
| CN112438922B (en) | Application of mangosteen fermentation liquor in preparation of composition for beautifying skin and/or reducing fat | |
| TWI737086B (en) | Fermentation method for increasing content of effective components in plants | |
| CN110151672B (en) | Application of lactobacillus plantarum GMNL-6 composition in skin care | |
| CN115607502A (en) | Composition containing sweet osmanthus extract and application and cosmetic thereof | |
| TWI774168B (en) | Morus alba ferment, manufacturing method thereof and use thereof | |
| TWI680772B (en) | A use of lactobacillus plantarum gmnl-6 composition for caring skin | |
| CA2901525C (en) | Cosmetic use of queuine | |
| JP2019119689A (en) | Skin condition improving agent | |
| CN118695846A (en) | Process for obtaining plant extracts comprising a self-fermentation step, compositions comprising such extracts and their cosmetic use | |
| FR2920300A1 (en) | Cosmetic use of hesperidin or its derivatives in combination with microorganism, one of its fractions or metabolites, as an agent e.g. to prevent reduction of barrier function of skin and/or strengthen barrier function of skin | |
| KR101738340B1 (en) | Composition for improving skin aging and wrinkle comprising Coptis teeta and Trichosanthes rosthornii mixed extract as effective component | |
| CN120436990B (en) | Triple composite acid composition with skin brightening and acne removing effects, product and application thereof | |
| TWI866695B (en) | Lacticaseibacillus paracaseitci077 and uses oflacticaseibacillus paracaseitci077 or it’s metabolite on conditioning skin and improving immunity | |
| TWI835500B (en) | Lactobacillus sakei and uses of lactobacillus sakei or it's metabolite for skin condition improvement |